Glanbia Plc ADR (OTCMKTS:GLAPY – Get Free Report) saw a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 145 shares, an increase of 98.6% from the September 15th total of 73 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 46 shares, the days-to-cover ratio is currently 3.2 days.
Glanbia Stock Performance
Shares of GLAPY stock traded down $8.60 during mid-day trading on Wednesday, hitting $108.40. The stock had a trading volume of 102 shares, compared to its average volume of 505. The company’s 50-day simple moving average is $125.14 and its 200-day simple moving average is $121.60. The company has a quick ratio of 0.84, a current ratio of 1.53 and a debt-to-equity ratio of 0.49. Glanbia has a fifty-two week low of $86.47 and a fifty-two week high of $143.50.
About Glanbia
Glanbia plc is an Ireland-based global nutrition company that develops, manufactures and markets performance, lifestyle and health-focused nutrition products. Its portfolio includes protein powders, bars, shakes, supplements and other nutritional products sold through retail, e-commerce, specialty and foodservice channels.
Through its Glanbia Performance Nutrition business, the company markets brands including Optimum Nutrition, Isopure, SlimFast and BSN. Glanbia Nutritionals supplies nutritional ingredients, premixes and solutions to food, beverage and supplement manufacturers, while its broader operations also include dairy and cheese activities serving consumer and commercial markets.
Glanbia traces its history to the Irish dairy cooperatives Avonmore and Waterford Foods, which merged in 1997 to form the company.
Recommended Stories
- Five stocks we like better than Glanbia
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
- How a Hurricane Could Help Some Refineries—and Hurt Others
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.
